Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

NCT ID: NCT02516540

Last Updated: 2024-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

BRCA1/2 mutation carriers have a considerably increased risk to develop breast and ovarian cancer during their lifetime. There is evidence from the literature that for sporadic breast cancer disease risk and the course of disease can be significantly influenced by physical activity, nutrition and weight. The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hereditary Breast and Ovarian Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Study participants are instructed regarding a healthy diet according to the recommendations of the German Nutrition Society (DGE) and are informed about positive effects of physical activity on incidence and prognosis of breast cancer

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Structured exercise training plus mediterranean diet: Study participants receive a lifestyle intervention of 12 months duration (3 months intensive intervention plus 9 months maintenance using monthly contacts and meetings). The intervention comprises a structured intensified training based on the results of physical performance diagnostics and a nutrition program based on a mediterranean diet.

Group Type EXPERIMENTAL

Structured exercise training plus mediterranean diet

Intervention Type BEHAVIORAL

Structured exercise training plus mediterranean diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structured exercise training plus mediterranean diet

Structured exercise training plus mediterranean diet

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* proven pathogenic BRCA1/2 mutation
* age \>=18
* written informed consent

Exclusion Criteria

* current chemotherapy of radiotherapy (inclusion 6 weeks after CTX or RX possible)
* metastatic tumor disease
* life expectancy \<3 years
* clinically limiting cardiovascular or respiratory disease (instable CVD, heart failure stage IV, COPD GOLD IV, maximum resting blood pressure 160/100 mmHg)
* significant orthopedic disability which prevents from participating in the group interventions
* severe concomitant diseases which prevents from participating in the group interventions
* Karnofsky index \<60
* maximum exercise capacity \<50 W
* food allergies which prevent from mediterranean diet
* vegan diet
* body mass index \<15 kg/m2
* pregnancy
* insufficient knowledge of German language
* insufficient compliance
* active participation in other interventional trials
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Hohenheim

OTHER

Sponsor Role collaborator

University Hospital Schleswig-Holstein

OTHER

Sponsor Role collaborator

University of Leipzig

OTHER

Sponsor Role collaborator

University of Cologne

OTHER

Sponsor Role collaborator

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marion Kiechle, Prof. Dr.

Role: STUDY_DIRECTOR

Technical University of Munich

Martin Halle, Prof. Dr.

Role: STUDY_DIRECTOR

Technical University of Munich

Stephan C Bischoff, Prof. Dr.

Role: STUDY_DIRECTOR

Universitaet Hohenheim, Stuttgart

Michael Siniatchkin, Prof. Dr.

Role: STUDY_DIRECTOR

University Hospital Schleswig-Holstein

Markus Loeffler, Prof. Dr.

Role: STUDY_DIRECTOR

University of Leipzig

Christoph Engel, PD Dr.

Role: STUDY_DIRECTOR

University of Leipzig

Rita K Schmutzler, Prof. Dr.

Role: STUDY_DIRECTOR

University of Cologne

Alfons Meindl, Prof. Dr.

Role: STUDY_DIRECTOR

Technical University of Munich

Anne S Quante, Dr.

Role: PRINCIPAL_INVESTIGATOR

Technical University of Munich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Humboldt Universität zu Berlin

Berlin, , Germany

Site Status RECRUITING

Uniklinikum Köln

Cologne, , Germany

Site Status RECRUITING

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

Dresden, , Germany

Site Status RECRUITING

Universitätsklinikum Düsseldorf

Düsseldorf, , Germany

Site Status RECRUITING

Kliniken Essen-Mitte

Essen, , Germany

Site Status RECRUITING

Universitätsklinikum Essen

Essen, , Germany

Site Status RECRUITING

Universitätsklinikum Freiburg

Freiburg im Breisgau, , Germany

Site Status RECRUITING

Universitätsmedizin Göttingen

Göttingen, , Germany

Site Status RECRUITING

Universitätsklinikum Hamburg-Eppendorf

Hamburg, , Germany

Site Status RECRUITING

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status RECRUITING

Universitätsklinium Heidelberg

Heidelberg, , Germany

Site Status RECRUITING

Universitätsklinikum Schleswig-Holstein, Campus Kiel

Kiel, , Germany

Site Status RECRUITING

Universitätsklinikum Leipzig

Leipzig, , Germany

Site Status NOT_YET_RECRUITING

Technische Universität München

München, , Germany

Site Status RECRUITING

Universität Regensburg

Regensburg, , Germany

Site Status RECRUITING

Interdisziplinäres Brustzentrum am Diakonieklinikum

Stuttgart, , Germany

Site Status RECRUITING

Universitätsklinikum Tübingen

Tübingen, , Germany

Site Status RECRUITING

Universität Ulm

Ulm, , Germany

Site Status RECRUITING

Universitätsklinikum Würzburg

Würzburg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marion Kiechle, Prof. Dr.

Role: CONTACT

+49 89 4140 2420

Daniela Schemmer

Role: CONTACT

+49 89 4140 2433

References

Explore related publications, articles, or registry entries linked to this study.

Seethaler B, Nguyen NK, Basrai M, Kiechle M, Walter J, Delzenne NM, Bischoff SC. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. Am J Clin Nutr. 2022 Oct 6;116(4):928-942. doi: 10.1093/ajcn/nqac175.

Reference Type DERIVED
PMID: 36055959 (View on PubMed)

Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff SC, Dukatz R, Siniatchkin M, Pfeifer K, Grill S, Yahiaoui-Doktor M, Kirsch E, Niederberger U, Enders U, Loffler M, Meindl A, Rhiem K, Schmutzler R, Erickson N, Halle M. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials. 2016 Jul 29;17:368. doi: 10.1186/s13063-016-1504-0.

Reference Type DERIVED
PMID: 27473440 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LIBRE-2-20150626

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Immunological Effects of Exercise in Cancer Patients
NCT05656651 ACTIVE_NOT_RECRUITING PHASE2